Page last updated: 2024-08-24

ibandronic acid and Acute Kidney Failure

ibandronic acid has been researched along with Acute Kidney Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Kaseda, R; Mitsuboshi, S; Narita, I1
Joensuu, TK1
Artunc, F; Friedrich, B; Georges, CG; Gröne, E; Guthoff, M; Müssig, K; Risler, T; Teichmann, R; Wehrmann, M1
Baraniskin, A; Schmiegel, W; Schroers, R1
Bergner, R; Bruckner, D; Henrich, DM; Hoffmann, M; Uppenkamp, M1
Bergner, R; Henrich, D; Hoffmann, M; Uppenkamp, M1

Reviews

1 review(s) available for ibandronic acid and Acute Kidney Failure

ArticleYear
[Emergencies in hematology and oncology].
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:38

    Topics: Acute Kidney Injury; Biopsy; Bone Density Conservation Agents; Carcinoma, Bronchogenic; Diphosphonates; Emergencies; Fatal Outcome; Fluid Therapy; Hemodiafiltration; Humans; Hypercalcemia; Ibandronic Acid; Lung; Lung Neoplasms; Male; Middle Aged; Palliative Care; Paraneoplastic Syndromes; Parathyroid Hormone; Parathyroid Hormone-Related Protein

2009

Other Studies

5 other study(ies) available for ibandronic acid and Acute Kidney Failure

ArticleYear
Association Between Antiosteoporotic Drugs and Risk of Acute Kidney Injury: A Cross-Sectional Study Using Disproportional Analysis and a Pharmacovigilance Database.
    Journal of clinical pharmacology, 2022, Volume: 62, Issue:11

    Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Alendronate; Cross-Sectional Studies; Databases, Factual; Denosumab; Diphosphonates; Humans; Ibandronic Acid; Osteoporosis; Pharmaceutical Preparations; Pharmacovigilance; Selective Estrogen Receptor Modulators; Teriparatide

2022
Renal toxicity following zoledronic acid reversed with ibandronate in a prostate cancer patient with bone metastases.
    Urologia internationalis, 2008, Volume: 80, Issue:4

    Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Bone Neoplasms; Creatinine; Diphosphonates; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Male; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Retreatment; Risk Assessment; Treatment Outcome; Zoledronic Acid

2008
[Hypercalcaemic crisis and acute renal failure due to primary hyperparathyroidism].
    Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:Suppl 0

    Topics: Acute Kidney Injury; Adenoma; Diphosphonates; Emergencies; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Ibandronic Acid; Middle Aged; Parathyroid Neoplasms; Renal Dialysis

2008
[Therapy of hypercalcemia with ibandronate in case of acute renal failure].
    Der Internist, 2006, Volume: 47, Issue:3

    Topics: Acute Kidney Injury; Adenoma; Aged; Bone Density Conservation Agents; Calcium; Creatinine; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Ibandronic Acid; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Recurrence

2006
Ibandronate for the treatment of hypercalcemia or nephrocalcinosis in patients with multiple myeloma and acute renal failure: Case reports.
    Acta haematologica, 2006, Volume: 116, Issue:3

    Topics: Acute Kidney Injury; Aged; Calcium; Creatinine; Diphosphonates; Fatal Outcome; Female; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Multiple Myeloma; Nephrocalcinosis

2006